ESCRS - PP20.01 - Corneal Epithelial And Refractive Alterations Associated With Belantamab Mafodotin Treatment In Patients Diagnosed With Refractory Multiple Myeloma

Corneal Epithelial And Refractive Alterations Associated With Belantamab Mafodotin Treatment In Patients Diagnosed With Refractory Multiple Myeloma

Published 2025 - 43rd Congress of the ESCRS

Reference: PP20.01 | Type: Poster | DOI: 10.82333/p7dr-ss69